The Centers for Medicare and Medicaid Services ("CMS") revealed that the percentage of Humana's membership in plans rated four stars or dropped to about 37% in July from 78% the previous year. On October 12, 2016, Humana informed public investors that the downgrade of the Company's Medicare rating might lower its federal reimbursements. Humana also said that it will take actions "to mitigate any potential negative impact of these published ratings on star bonus revenues for 2018," including seeking reconsideration of some ratings. Following this news, Humana stock dropped $9.09 per share, or 5.12%, to close at $168.44 on October 12, 2016.
If you are aware of any facts relating to this investigation, or if you purchased shares of Humana, you can assist this investigation by visiting the firm's site: http://www.bgandg.com/hum or by contacting Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email firstname.lastname@example.org. Those who inquire by e-mail are encouraged to include their mailing address, email and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-humana-inc-hum-300344969.html
SOURCE Bronstein, Gewirtz & Grossman, LLC